(Q33348965)

26 July 2017

1 reference

title

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies (English)

1 reference

26 July 2017

Manfred Rauh

3

0 references

author name string

Amiram Nir

1

1 reference

26 July 2017

Angelika Lindinger

2

1 reference

26 July 2017

Benjamin Bar-Oz

4

1 reference

26 July 2017

Stephanie Laer

5

1 reference

26 July 2017

Lynn Schwachtgen

6

1 reference

26 July 2017

Andreas Koch

7

1 reference

26 July 2017

Jan Falkenberg

8

1 reference

26 July 2017

Thomas S Mir

9

1 reference

26 July 2017

4 July 2008

1 reference

26 July 2017

1 reference

26 July 2017

30

1 reference

26 July 2017

1

1 reference

26 July 2017

3-8

1 reference

https://scigraph.springernature.com/pub.10.1007/s00246-008-9258-4

26 July 2017

0 references

cites work

N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases

1 reference

12 December 2020

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

1 reference

12 December 2020

Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients.

1 reference

12 December 2020

Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth.

1 reference

12 December 2020

Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn

1 reference

12 December 2020

Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.

1 reference

12 December 2020

Concentrations of brain natriuretic peptide in the plasma predicts outcomes of treatment of children with decompensated heart failure admitted to the Intensive Care unit.

1 reference

12 December 2020

Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy

1 reference

12 December 2020

Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

1 reference

12 December 2020

Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.

1 reference

12 December 2020

BNP and congestive heart failure

1 reference

12 December 2020

Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases

1 reference

12 December 2020

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

1 reference

12 December 2020

Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth

1 reference

12 December 2020

Sorting out the evidence on natriuretic peptides

1 reference

12 December 2020

Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.

1 reference

12 December 2020

Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender.

1 reference

12 December 2020

Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.

1 reference

12 December 2020

B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.

1 reference

12 December 2020

Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease.

1 reference

12 December 2020

Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.

1 reference

12 December 2020

Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease

1 reference

12 December 2020

Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?

1 reference

12 December 2020

Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.

1 reference

12 December 2020

Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease

1 reference

12 December 2020

B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.

1 reference

12 December 2020

Normal values of B type natriuretic peptide in infants, children, and adolescents

1 reference

12 December 2020

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

1 reference

12 December 2020

Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease

1 reference

12 December 2020

Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker

1 reference

12 December 2020

N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability

1 reference

12 December 2020

Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease.

1 reference

12 December 2020

10.1007/S00246-008-9258-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference